Literature DB >> 9593430

Statins and fibrinogen.

D R Nair, J A Papadakis, I A Jagroop, D P Mikhailidis, A F Winder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9593430     DOI： 10.1016/s0140-6736(98)26019-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

Review 1.  Atorvastatin: an updated review of its pharmacological properties and use in dyslipidaemia.

Authors:  H S Malhotra; K L Goa
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 2.  Lipoprotein (a) and stroke.

Authors:  H J Milionis; A F Winder; D P Mikhailidis
Journal:  J Clin Pathol       Date:  2000-07       Impact factor: 3.411

Review 3.  Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes.

Authors:  Robert Krysiak; Boguslaw Okopień; Zbigniew Herman
Journal:  Drugs       Date:  2003       Impact factor: 9.546

4.  Effect of Atorvastatin versus Simvastatin on Lipid Profile and Plasma Fibrinogen in Patients with Hypercholesterolaemia: A Pilot, Randomised, Double-Blind, Dose-Titrating Study.

Authors:  V G Athyros; A A Papageorgiou; H A Hatzikonstandinou; V V Athyrou; A G Kontopoulos
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.